Holdings of Rosalind Advisors, Inc.
25 declared positions · as of Mar 31, 2026
Original filing · Ten largest lines: 78.4 % of the equity sleeve
Sector breakdown
- Unattributed 100.0 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
- USD 100.0 %
The quoted currency of each line, as declared.
Country breakdown
- US 100.0 %
Shares computed on the equity sleeve.
| Country | Lines | Value | Share |
|---|---|---|---|
| US | 25 | 195.7M $ | 100.00 % |
Positions
| Company | Shares | Value | Weight |
|---|---|---|---|
| Delcath Systems Inc | 3,300,389 | 30.6M $ | |
| Xeris Biopharma Holdings Inc | 3,231,700 | 18.7M $ | |
| Savara Inc | 3,203,721 | 17.5M $ | |
| Vaxcyte Inc | 290,000 | 16.9M $ | |
| EyePoint Inc | 1,036,737 | 13.4M $ | |
| X4 PHARMACEUTICALS INC | 3,214,766 | 13.3M $ | |
| Vor BioPharma Inc | 700,000 | 12.5M $ | |
| Verastem Inc | 2,138,475 | 11.3M $ | |
| Celldex Therapeutics Inc | 330,000 | 10.5M $ | |
| BioCryst Pharmaceuticals Inc | 923,057 | 8.8M $ | |
| CG oncology Inc | 100,000 | 6.8M $ | |
| InspireMD, Inc. | 3,905,743 | 6.4M $ | |
| Atea Pharmaceuticals Inc | 1,171,855 | 6.3M $ | |
| Viridian Therapeutics Inc | 250,401 | 4.9M $ | |
| Myomo Inc | 3,847,272 | 2.6M $ | |
| TALPHERA INC | 3,353,916 | 2.5M $ | |
| Ovid therapeutics Inc | 1,107,994 | 2.5M $ | |
| OnKure Therapeutics Inc | 443,763 | 1.8M $ | |
| Lipocine Inc | 221,616 | 1.8M $ | |
| NEURAXIS INC | 286,138 | 1.7M $ | |
| AVALO THERAPEUTICS INC | 75,000 | 1.1M $ | |
| Annexon Inc | 200,000 | 1.1M $ | |
| Aquestive Therapeutics Inc | 250,000 | 1M $ | |
| BIOFRONTERA INC | 1,163,962 | 941.6K $ | |
| Kura Oncology Inc | 100,000 | 813K $ |